Shoulder Innovations, Inc. planned insider sales
In the last twelve months insiders at Shoulder Innovations, Inc. filed 4 Form 144 notices of planned sales, 252,675 shares worth $5.9 million at the time of filing, from 3 sellers. The latest, filed 14 September 2026: Robert Ball (officer, director), 10,175 shares worth $187,706, planned for around 14 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 14 September 2026 | Robert Ball | Officer, Director | 10,175 | $187,706 | 14 September 2026 | 10,175 shares from 14 September 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Private Acquisition from Issuer/Affiliate | Form 144 |
| 17 August 2026 | Matthew Ahearn | Director, Officer | 22,500 | $466,425 | 17 August 2026 | 22,500 shares from 17 August 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Preferred Equity Financing | Form 144 |
| 29 July 2026 | Gilde Healthcare Holding B.V.; Cooperatieve Gilde Healthcare V U.A. | 10% Stockholder | 200,000 | $4.8 million | 29 July 2026 | 194,568 shares from 30 July 2026 | Van Lanschot Kempen N.V. | Private placement of Series D convertible preferred stock; converted into common stock upon IPO closing 08/01/2025. Holding period tacks under Rule 144(d)(3)(ii).; Private placement of Series E convertible preferred stock; converted into common stock upon IPO closing 08/01/2025. Holding period tacks under Rule 144(d)(3)(ii).; Purchase in the issuer's registered initial public offering at $15.00 per share. Not restricted securities; sold as control securities. | Form 144 |
| 12 June 2026 | Matthew Ahearn | Director, Officer | 20,000 | $375,200 | 12 June 2026 | 20,000 shares from 12 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Preferred Equity Financing | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.